Levodopa–carbidopa intestinal gel in advanced Parkinson’s disease: long-term results from COSMOS

被引：0
作者：
Alfonso Fasano
Rocío García-Ramos
Tanya Gurevich
Robert Jech
Lars Bergmann
Olga Sanchez-Soliño
Juan Carlos Parra
Mihaela Simu
机构：
[1] University of Toronto,Edmond J Safra Program in Parkinson’s Disease and the Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital
[2] Krembil Research Institute,UHN, Division of Neurology
[3] Complutense University of Madrid,Movement Disorders Unit, San Carlos Clinical Hospital
[4] Tel Aviv University,Movement Disorders Unit, Neurological Institute, Tel Aviv Medical Center
[5] Charles University in Prague and General University Hospital in Prague,Department of Neurology and Center of Clinical Neurosciences, 1st Faculty of Medicine
[6] AbbVie Inc.,undefined
[7] Victor Babes University of Medicine and Pharmacy,undefined
来源：
Journal of Neurology | 2023年 / 270卷
关键词：
Parkinson's disease; Long-term treatment; Dyskinesia; Motor symptoms; Nonmotor symptoms;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2765 / 2775
页数：10
相关论文
共 347 条
  • [1] Hauser RA(2009)Levodopa: past, present, and future Eur Neurol 62 1-8
  • [2] Antonini A(2017)Levodopa–carbidopa intestinal gel in advanced Parkinson's: final results of the GLORIA registry Parkinsonism Relat Disord 45 13-20
  • [3] Poewe W(2008)Optimizing levodopa therapy for Parkinson's disease with levodopa/carbidopa/entacapone: implications from a clinical and patient perspective Neuropsychiatr Dis Treat 4 39-47
  • [4] Chaudhuri KR(2018)Levodopa–carbidopa intestinal gel in Parkinson's disease: a systematic review and meta-analysis Front Neurol 9 620-481
  • [5] Jech R(1996)Pharmacokinetic optimisation in the treatment of Parkinson's disease Clin Pharmacokinet 30 463-1252
  • [6] Pickut B(2016)Flow-metabolism dissociation in the pathogenesis of levodopa-induced dyskinesia JCI Insight 1 1239-458
  • [7] Pirtosek Z(2018)Levodopa in Parkinson's disease: current status and future developments Curr Neuropharmacol 16 448-535
  • [8] Szasz J(2001)Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature Mov Disord 16 529-1047
  • [9] Valldeoriola F(1999)Parkinson disease, the effect of levodopa, and the ELLDOPA trial. Earlier vs Later L-DOPA Arch Neurol 56 1041-421
  • [10] Winkler C(2001)Gastric emptying time and gastric motility in patients with Parkinson's disease Mov Disord 16 419-S72
12345678910